1. Home
  2. IXHL

IXHL

Incannex Healthcare Inc.

Logo Incannex Healthcare Inc.

as 04-19-2024 11:43am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Founded: 2001 Country:
Australia
Australia
Employees: 10 City: DOCKLANDS, VICTORIA
Market Cap: 38.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 322.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.69 EPS Growth: N/A
52 Week Low/High: $0.80 - $12.68 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: